Director, Global Marketing Oncology

MSD•North Wales, PA

9d•$190,800 - $300,300•Hybrid

About The Position

The Global Marketing Director will lead commercial strategy for a novel bispecific antibody with the potential to represent an innovative approach to cancer treatment. The role is responsible for developing foundational commercial insights, shaping global asset and portfolio strategy, and advancing launch preparedness. The Director will partner with disease and asset teams and cross-functional stakeholders—including clinical, regulatory, medical affairs, market access, regional, and brand strategy teams—to position the asset for successful development and future commercialization. The role requires approximately 15–20% travel, including some weekends.

Requirements

Bachelor's degree.
At least 8 years of commercial experience in the pharmaceutical or biotechnology industry, including experience in marketing, sales, market access, pricing, and/or marketing support.
Understanding of oncology market dynamics, scientific innovation, healthcare policy, reimbursement, and access considerations.
Experience developing and implementing strategy in a complex, cross-functional environment.
Strong business acumen and analytical capability, with the ability to drive key initiatives forward.
Demonstrated collaboration across commercial, cross-divisional, regional, and local teams.
Strong leadership, problem-solving, written and verbal communication, and presentation skills.
Ability to influence without authority and communicate clearly across the enterprise and with senior leadership.
Approximately 15–20% travel, including some weekends.

Nice To Haves

Advanced degree, such as an MBA.
Global marketing experience.
Oncology experience.
Launch planning or launch execution experience.
Pipeline, early asset, or clinical development experience.
Experience providing commercial input into target product profiles, regulatory filing strategy, launch readiness reviews, market research, organized customer engagement, demand and revenue forecasting, P&L forecasting, BD&L activities, product development teams, or agency partner management.
Experience partnering with finance and business planning teams to support brand forecasting and S&OP processes.
Previous team leadership experience.

Responsibilities

Lead development of the global commercial strategy for the bispecific antibody, using the early L3 strategic framework and aligning asset priorities with broader disease-area and portfolio strategies.
Partner with asset and disease teams to define indication-specific commercial strategies.
Provide commercial guidance for clinical development planning, target product profile refinement, and evidence-generation priorities.
Oversee market research and insight generation in collaboration with disease-area, asset, brand strategy, and market research partners.
Guide forecasting, opportunity assessment, and market-shaping analyses to inform planning assumptions, investment decisions, and strategic trade-offs.
Establish a bispecific landscape tracking and data-monitoring plan to assess performance, competitive dynamics, and positioning implications.
Establish and manage launch-planning milestones, timelines, and activities to support future commercialization readiness.
Drive early commercial planning, including market development, lexicon development, scientific platform development, and customer engagement planning.
Guide generic name, brand name, and trademark development in partnership with internal stakeholders.
Build relationships with global commercial disease, asset, and brand strategy teams and cross-functional partners across clinical, regulatory, manufacturing, market access, medical affairs, HEOR, publications, forecasting, finance, legal, compliance, regional, and local functions.
Serve as the commercial point of contact for medical affairs, publications, HEOR, and related workstreams supporting the asset.
Partner with regions and key markets to incorporate customer insights, launch considerations, and local market dynamics into global strategy.